Oliver C. Watkins

Singapore, 138602, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Multi-Mycotoxin Quantification in Soy Protein Powders, Soymilk, Soybeans (Glycine max) and Other Legumes Using a New Targeted Differential Ion Mobility LCMS Method.

Multi-Mycotoxin Quantification in Soy Protein Powders, Soymilk, Soybeans (Glycine max) and Other Legumes Using a New Targeted Differential Ion Mobility LCMS Method.

Journal: Journal of agricultural and food chemistry

Published: April 13, 2026

Myo-inositol alters the effects of glucose, leptin and insulin on placental palmitic acid and oleic acid metabolism.

Myo-inositol alters the effects of glucose, leptin and insulin on placental palmitic acid and oleic acid metabolism.

Journal: The Journal of physiology

Published: May 21, 2023

Increasing maternal age associates with lower placental CPT1B mRNA expression and acylcarnitines, particularly in overweight women.

Increasing maternal age associates with lower placental CPT1B mRNA expression and acylcarnitines, particularly in overweight women.

Journal: Frontiers in physiology

Published: February 21, 2023

Myo-Inositol Moderates Glucose-Induced Effects on Human Placental 13C-Arachidonic Acid Metabolism.

Myo-Inositol Moderates Glucose-Induced Effects on Human Placental 13C-Arachidonic Acid Metabolism.

Journal: Nutrients

Published: August 23, 2022

Sex-Dependent Regulation of Placental Oleic Acid and Palmitic Acid Metabolism by Maternal Glycemia and Associations with Birthweight.

Sex-Dependent Regulation of Placental Oleic Acid and Palmitic Acid Metabolism by Maternal Glycemia and Associations with Birthweight.

Journal: International journal of molecular sciences

Published: June 16, 2022

Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental 13C-DHA-metabolism, altering their relationships with birthweight.

Myo-inositol moderates maternal BMI and glycemia related variations in in-vitro placental 13C-DHA-metabolism, altering their relationships with birthweight.

Journal: Scientific reports

Published: December 13, 2021

Myo-inositol: a potential prophylaxis against premature onset of labour and preterm birth.

Myo-inositol: a potential prophylaxis against premature onset of labour and preterm birth.

Journal: Nutrition research reviews

Published: September 16, 2021

Placental 13C-DHA metabolism and relationship with maternal BMI, glycemia and birthweight.

Placental 13C-DHA metabolism and relationship with maternal BMI, glycemia and birthweight.

Journal: Molecular medicine (Cambridge, Mass.)

Published: May 02, 2021

A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy.

A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy.

Journal: Critical reviews in food science and nutrition

Published: December 07, 2020

Placental Inositol Reduced in Gestational Diabetes as Glucose Alters Inositol Transporters and IMPA1 Enzyme Expression.

Placental Inositol Reduced in Gestational Diabetes as Glucose Alters Inositol Transporters and IMPA1 Enzyme Expression.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 18, 2020

Myo-inositol alters 13C-labeled fatty acid metabolism in human placental explants.

Myo-inositol alters 13C-labeled fatty acid metabolism in human placental explants.

Journal: The Journal of endocrinology

Published: July 19, 2019

An enzymatic assay for quantification of inositol in human term placental tissue.

An enzymatic assay for quantification of inositol in human term placental tissue.

Journal: Analytical biochemistry

Published: June 20, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026